Precipio, Inc. PRPO
NASDAQ · United States · Health Services
$22.73-0.95 (-4.01%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Precipio Inc (PRPO) surpasses $7 million in quarterly revenue, achieves positive adjusted EBITDA, and generates strong operating cash flow.
Moby summary of Precipio, Inc.'s Q2 2026 earnings call
Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash positionNEW HAVEN, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the second quarter that ended June 30, 2026. Below are some of the key financial performance metrics for the Company. For additional results please see the Company’s Form 10-Q which was filed today. Revenue – $7.0M vs. $6.7M in Q1-2026, a
Conference Call will be held on August 17th, 2026, at 5:00 PM EDTNEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at 5:00 PM ET. The call will include remarks on the company’s current core businesses, as well as a moderated live Q&A session at the end of the Company remarks. “We are excited to share our upcoming results for Q2. The team continues to mak
NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately. Votes must be received by 11:59 p.m., Eastern Time, on June 14, 2026, to be voted at the Annual Meeting. In order to ensure that there is a quorum required for the shareholders’ meeting that is scheduled to take place tomorrow, June 15, 2026, at 10 a.m. Eastern Time. At the tim
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, 2026, at 9:00 AM (Local Time, 12:00pm EST) at the Bellagio Resort & Hotel. Ilan Danieli, CEO and Zaki Sabet, COO of Precipio will be hosting the presentation and answering questions at the conclusion. “We’re excited to participate in the Planet MicroCap conference and are looking f
Precipio Inc (PRPO) reports a 30% year-over-year revenue increase, while facing margin pressures and a negative EBITDA in Q1 2026.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.